This case study examines the treatment of a 54-year-old female patient who presented with persistent pain in her right arm, shoulder, neck, and chest following an accidental fall. The patient’s injury occurred five to six weeks prior to her initial consultation, during which she fell down a flight of stairs, sustaining a significant impact to her right arm and head.
Following the initial accident, the patient sought care at an emergency department, where she was diagnosed with bruising of the chest and soft tissues. Despite this initial assessment, she continued to suffer from restricted range of motion in her right arm, an inability to fully raise her arm, and frequent headaches.
Upon an objective examination at the clinic, the attending physician identified soreness and palpable muscle lumps along the right side of the chest, the ribs, the spine, the right shoulder, and the collarbone, as well as the right side of the neck. The clinical diagnosis was confirmed as the consequences of bruising to the chest and soft tissues of the head and right arm, complicated by post-traumatic neuropathy of the right brachial plexus. The patient reported a moderate pain syndrome, rated at three to four points on the visual analog scale.
To address these injuries, the patient underwent a course of coMra therapy consisting of 10 treatments, administered once daily. coMra therapy, developed by Radiant Life Technologies, utilizes a unique combination of low-level laser, LED colour light, magnetic fields, and ultrasound to support the body’s innate healing capacity.
Following the 10-session course, the patient reported a significant reduction in arm pain. Her range of motion showed marked improvement, increasing from 40–45% of the norm to 70–75%. She regained the ability to perform full circular movements in her shoulder, reporting only minor discomfort during these actions.
While the patient noted that some pain persisted at night, the intensity was notably reduced compared to her pre-treatment state. Based on these positive results, it was recommended that the patient continue with further coMra therapy sessions after a three-to-four-month interval, depending on her ongoing health status and recovery progress.